Human breast cancer progression can be regulated by dominant trans- acting factors in somatic cell hybridization studies

Cancer Research

Volumn 56, Issue 15, 1996, Pages 3560-3569

  Safarians, Suzi ^a   Sternlicht, Mark D ^a   Yamanishi, Douglas T ^b   Love, Susan M ^a   Barsky, Sanford H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GROWTH; CANCER HORMONE THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; BREAST NEOPLASMS; CELL FUSION; DISEASE PROGRESSION; FEMALE; HUMANS; HYBRID CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; TRANSFECTION;

EID: 0029682494     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Nowell, P. C. Molecular events in tumor development N. Engl. J. Med., 319: 575-577, 1988.
2. Liotta, L. A., Steeg, P. S., and Steller-Stevenson, W. G. Cancer metastasis and angiogenesis, an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
3. Walker, R. A., and Varley, J. M. The molecular pathology of human breast cancer. Cancer Surv., 16: 31-57, 1993.
4. Weigel, R. J., and deConinck, E. C. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res., 53: 3472-3474, 1993.
5. Miller, D. L., el-Ashry, D., Cheville, A. L., Liu, Y., McLeskey, S. W., and Kern, F. G. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role in breast cancer growth and progression Cell Growth & Differ., 5: 1263-1274, 1994.
6. van Agthoven, T., van Agthoven, T. L., Thecla, L. A., Portengen, H., Foekens, J. A., and Dorssers, L. C. Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res., 52: 5082-5088, 1992.
7. Sheikh, M. S., Shao, Z. M., Chen, J. C., Li, X. S., Hussain, A., and Fontana, J. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor α (TGF-α) gene expression J. Cell Biochem., 54: 289-298, 1994.
8. Zajchowski, D. A., Band, V., Trask, D. K., Kling, D., Connolly, J. L., and Sager, R. Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells Proc. Natl. Acad. Sci. USA, 87: 2314-2318, 1990.
9. Welch, D., Bisi, J., Miller, B., Conway, D., Seftor, E., Yohem, K., Gilmore, L., Seftor, R., Nakajima, M., and Hendrix, M. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma line. Int. J. Cancer, 47: 227-237, 1991.
10. Davidson, R. L., and Gerald, P. S. Improved techniques for the induction of mammalian cell hybridization by polyethylene glycol. Somatic Cell Genet., 2: 165-176, 1976.
11. Fu, Y. S., Cheng, L., Huang, I., Huang, S., Wiesmier, E., Wettstein, F., and Weissman, M. DNA ploidy analysis of cervical condyloma and intraepithelial neoplasia in specimens obtained by punch biopsy. Anal. Quant. Cytol. Histol., 11: 187-195, 1989.
12. Staroselsky, A. H., Pathak, S., Chernajovsky, Y., Tucker, S. L., and Fidler, I. J. Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Res., 51: 6292-6298, 1991.
13. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
14. Hunter, W. M., and Greenwood, F. C. A radio-immunoelectrophoretic assay for human growth hormone. Biochem. J., 91: 43-56, 1964.
15. Merlino, G. T., Ishii, S., Whang-Peng, J., Knutsen, T., Xu, Y. H., Clark, A. J. L., Stratton, R. H., Wilson, R. K., Ma, D. P., Roe, B. A., Hunts, J. H., Shimizu, N., and Pastan, I. Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol. Cell Biol., 5: 1722-1734, 1985.
16. Katzenellenbogen, B. S., Kendra, K. L., Norman, M. J., and Berthois, Y. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens Cancer Res., 47: 4355-4360, 1987.
17. Wooge, C. H., Nilsson, G. M., Heierson, A., McDonnell, D. P., and Katzenellenbogen, B. S. Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis of truncated and full-length estrogen receptors expressed in bacteria, yeast and mammalian cells Mol. Endocrinol., 6: 861-869, 1992.
18. Greene, G. L., Nolan, C., Engler, J. P., and Jensen, E. V. Monoclonal antibodies to human estrogen receptor. Proc. Natl. Acad. Sci. USA, 77: 5115-5119, 1980.
19. Cheng, L., Binder, S. W., Fu, Y. S., and Lewin, K. J. Demonstration of estrogen receptors by monoclonal antibody in formalin-fixed breast tumors Lab. Invest., 58: 346-353, 1988.
20. Visakorpi, T., Kallioniemi, O. P., Koivula, T., Harvey, J., and Isola, J. Expression of epidermal growth factor receptor and ERBB2 (Her-2/neu) oncoprotein in prostatic carcinomas. Mod. Pathol. 5: 643-648, 1992.
21. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J. M., Argos, P., and Chambon, P. Human estrogen receptor cDNA sequence, expression, and homology to v-erb-A Nature (Lond.), 320: 134-139, 1986.
22. Xu, Y. H., Ishii, S., Clark, A. J. L., Sullivan, M., Wilson, R. K., Ma, D. P., Roe, B. A., Merlino, G. T., and Pastan, I. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature (Lond.), 309: 806-810, 1984.
23. Steeg, P. S., Bevilacqua, G., Kopper, L., Thorgeirsson, U. P., Talmadge, J. E., Liotta, L. A., and Sobel, M. E. Evidence for a novel gene associated with low rumor metastatic potential. J. Natl. Cancer Inst., 80: 200-204, 1988.
24. Yen, R. C., Vertino, P. M., Nelkin, B. D., Yu, J. J., El-Deiry, W., Cumaraswamy, A., Lennon, G. G., Trask, B. J., Celano, P., and Baylin, S. T. Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res., 20: 2287-2291, 1992.
25. Sharma, R. C., Murphy, A. J. M., DeWald, M. G., and Schimke, R. T. A rapid procedure for isolation of RNA-free genomic DNA from mammalian cells. Biotechniques, 14: 176-178, 1993.
26. Reed, K. C., and Mann, D. A. Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res., 13: 7207-7221, 1985.
27. Nevins, J. R. Isolation and analysis of nuclear RNA. In: S. L. Berger and A. R., Kimmel (eds.), Methods in Enzymology, pp. 234-241. Orlando, FL: Academic Press, Inc., 1987.
28. Roder, J. C., Kiessling, R., Biberfeld, P., and Andersson, B. Target-effector interaction in the natural killer (NK) cell system the isolation of NK cells and studies on the mechanism of killing J. Immunol., 121: 2509-2517, 1987.
29. Raz, A., Fogler, W. E., and Fidler, I. J. The effects of experimental conditions on the expression of in vitro-mediated tumor cytotoxicity mediated by murine macrophages. Cancer Immunol. Immunother., 7: 157-163, 1979.
30. Thorgeirsson, U. P., Turpeenniemi-Hujanen, T., Williams, J. E., Westin, E. H., Heilman, C. A., Talmadge, J. E., and Liotta, L. A. NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol. Cell. Biol., 5: 259-262, 1985.
31. Castagnoli, A., Maestri, I., Bernardi, F., and Del-Senno, L. PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res., 15: 866, 1987.
32. Ottaviano, Y. L., Issa, J. P., Parl, F. F., Smith, H. S., Baylin, S. B., and Davidson, N. E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res., 54: 2552-2555, 1994.
33. Issa, J. P. J., Vertino, P. M., Wu, J., Sazawal, S., Celano, P., Nelkin, B. D., Hamilton, S. R., and Baylin, S. B. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J. Natl. Cancer Inst., 85: 1235-1240, 1993.
34. Baylin, S. B., Makos, M., Wu, J., Yen, R., De Bustros, A., Vertino, P., and Nelkin, B. D. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells (Cold Spring Harbor), 3: 383-390, 1991.
35. El-Deiry, W. S., Nelkin, B. D., Celano, P., Yen, R. C., Falco, J. P., Hamilton, S. R., and Baylin, S. B. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc. Natl. Acad. Sci. USA, 88: 3470-3474, 1991.
36. Ferguson, A. T., Lapidus, R. G., Baylin, S. B., and Davidson, N. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res., 55: 2279-2283, 1995.
37. Tzukerman, M., Zhang, X. K., and Pfahl, M. Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis. Mol. Endocrinol., 5: 1983-1992, 1991.
38. H. Cancer Res., 50: 67-71, 1990.
39. Bevilacqua, G., Sobel, M. E., Liotta, L. A., and Steeg, P. S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res., 49: 5185-5190, 1989.
40. Tokunaga, Y., Urano, T., Furukawa, K., Kondo, H., Kanematsu, T., and Shiku, H. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int. J. Cancer, 55: 66-71, 1993.
41. Davidoff, A. M., Kerns, B. J. M., Iglehart, J. D., and Marks, J. R. Maintenance of p53 alterations throughout breast cancer. Cancer Res., 51: 2605-2610, 1991.
42. McLeskey, S. W., Kurebayashi, J., Honig, S. F., Zwiebel, J., Lippman, M. E., Dickson, R. B., and Kern, F. G. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res., 53: 2168-2177, 1993.
43. Delli-bovi, P., Curatola, A. M., Newman, K. M., Sato, Y., Moscatelli, D., Hewick, R. M., Rifkin, D. B., and Basilico, C. Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol. Cell. Biol., 8: 2933-2941, 1988.
44. Walter, P., Green, S., Greene, G., Krust, A., Bornert, J. M., Jeltsch, J. M., Staub, A., Jensen, E., Scrace, G., Waterfield, M., and Chambon, P. Cloning of the human estrogen receptor. Proc. Natl. Acad. Sci. USA, 82: 7889-7893, 1985.
45. Piva, R., Kumar, L. V., Hanau, S., Maestri, I., Rimondi, A. P., Pansini, S. F., Mollica, G., Chambon, P., and del Senno, L. The methylation pattern in the 5′ end of the human estrogen receptor gene is tissue specific and related to the degree of gene expression. Biochem. Int., 19: 267-275, 1989.
46. Nembrot, M., Quintana, B., and Mordoh, L. Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumors. Biochem. Biophys. Res. Commun., 166: 601-607, 1990.
47. Rio, M. C., Bellocq, J. P., Gairard, B., Rasmussen, U. B., Krust, A., Koehl, C., Calderoli, H., Schiff, V., Renaud, R., and Chambon, P. Specific expression of the pS2 gene in subclasses of breast cancers in companion with expression of the estrogen and progesterone receptors and the oncogene ERB2. Proc. Natl. Acad. Sci. USA, 84: 9243-9247, 1987.
48. Tandon, A. K., Clark, G. M., Chamness, G. C., Chirgwin, J. M., and McGuire, W. L. Cathepsin D and prognosis in breast cancer. N. Engl. J. Med., 322: 297-302, 1990.
49. Kumar, V., Green, S., Stack, G., Berry, M., Jin, J., and Chambon, P. Functional domains of the human estrogen receptor. Cell, 51: 941-951, 1987.
50. McGuire, W. L., Chamness, G. C., and Fuqua, S. A. Abnormal estrogen receptor in clinical breast cancer. J. Steroid Biochem. Mol. Biol., 43: 243-247, 1992.
51. Leslie, K. K., Tasset, D. M. and Horwitz, K. B. Functional analysis of a mutant estrogen receptor isolated from T47D breast cancer cells. Am. J. Obstet. Gynecol., 166: 1053-1061, 1992.
52. Pakdel, F., and Katzenellenbogen, B. S. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination. J. Biol. Chem., 267: 3429-3437, 1992.
53. Fuqua, S. A., Chamness, G. C., and McGuire, W. L. Estrogen receptor mutations in breast cancer. J. Cell. Biochem., 51: 135-139, 1993.
54. Fuqua, S. A., Fitzgerald, S. D., Allred, D. C., Elledge, R. M., Nawaz, Z., McDonnell, D. P. O'Malley, B. W., Greene, G. L., and McGuire, W. L. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res., 52: 483-486, 1992.
55. Fuqua, S. A., Fitzgerald, S. D., Chamness, G. C., Tandon, A. K., McDonnell, D. P., Nawaz, Z., O'Malley, B., and McGuire, W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res., 51: 105-109, 1991.
56. Henry, J. A., Nicholson, S., Farndon, J. R., Westley, B., and May, F. E. Measurements of estrogen receptor mRNA levels in human breast tumours. Br. J. Cancer, 58: 600-605, 1988.
57. deConinck, E. C., McPherson, L. A., and Weigel, R. J. Transcriptional regulation of estrogen receptor in breast carcinomas. Mol. Cell. Biol., 15: 2191-2196, 1995.
58. Le Roux, M. G., Thézé, N., Wolff, J., and Le Pennec, J. P. Organization of a rainbow trout estrogen receptor gene. Biochim. Biophys. Acta, 1172: 226-230, 1993.
59. Keaveney, M., Klug, J., and Gannon, F. Sequence analysis of the 5′ flanking region of the human estrogen receptor gene. DNA Seq., 2: 347-358, 1992.
60. Katzenellenbogen, B. S. Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. J. Natl. Cancer Inst., 83: 1434-1435, 1991.
61. Garcia, M., Derocq, D., Freiss, G., and Rochefort, H. Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc. Natl. Acad. Sci. USA, 89: 11538-11542, 1992.
62. Cho, H. S., Ng, P. A., and Katzenellenbogen, B. S. Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines. Mol. Endocrinol., 5: 1323-1330, 1991.
63. Thompson, E. W., Brunner, N., Torri, J., Johnson, M. D., Boulay, V., Wright, A., Lippman, M. E., Steeg, P. S., and Clarke, R. The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin. & Exp. Metastasis, 11: 15-26, 1993.
64. Sainsbury, J. R., Farndon, J., Needham, G. K., Malcolm, A. J., and Harris, A. L. Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet, 1: 1398-1402: 1987.
65. Van de Vijver, M. J., Peterse, J. L., Mooi, W. J., Wisman, P., Lomans, J., Dalesio, O., and Nusse, R. Neu-protein overexpression in breast cancer. N. Engl. J. Med., 319: 1239-1245, 1988.
66. Allred, D. C., Clark, G. M., Molina, R., Tandon, A. K., Schnitt, S. J., Gilchrist, K. W., Osborne, C. K., Tormey, D. C., and McGuire, W. L. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum. Pathol., 23: 974-979, 1992.